Advising Axéréal, a leading agribusiness cooperative group, in connection with its first private placement of bonds, a Euro PP, with a fundraising of € 150 million.

With various concomitant financing transactions, Axéréal has raised in the aggregate 1.2 billion euros in connection with the refinancing of its activities and its development.

CONTACTS

    * Aurélie Paneels
    * Corentin Coatalem
    * Eléonore Delplanque de Mandelot

Mithra Pharmaceuticals, a pharmaceutical company focused on women’s health, on 1 July successfully closed its IPO on Euronext Brussels, thereby raising EUR 72.3 million (without taking into account the exercise of the over-allotment option, if any).

Eubelius is proud to have acted as counsel to Mithra in respect of this successful IPO on Euronext Brussels. The Eubelius team was led by Lars Van Bever and Michael Truyen.

NautaDutilh together with Sidley Austin LLP successfully assisted Kempen & Co, KBC Securities, and Peel Hunt in their role as underwriters in the initial public offering of Kiadis Pharma N.V. and the listing of its shares on the Amsterdam and Brussels market of Euronext.

King & Wood Mallesons (“KWM”) advised Huatai Securities Company Limited (“Huatai Securities”) on its successful Hong Kong IPO and H-share issuance (Company Name: HTSC; Stock Code: 06886). Huatai issued 1.4 billion shares priced at HK$24.80 per share and raised approximately HK$34.72 billion, among which 162,768,800 H-shares were under the overallotment option, which was exercised by the joint global coordinator of Huatai Securities on June 24.

Nabarro has advised Investec on the main market IPO of Kainos Group plc, the UK-based provider of IT services, consulting and software solutions. Investec was acting as sponsor in relation to the transaction which gives Kainos a market capitalisation of £161.3 million.

Kainos operates through three divisions: digital consulting (providing full system development mainly to UK government); Evolve (the market leader for the digitisation of patient records in the UK); and Workday implementation (the implementation of Workday human capital management systems).

Herbert Smith Freehills has advised Murray Goulburn Co-operative Co. Limited (Murray Goulburn) on the implementation of a transformative new capital structure and successful A$500 million capital raising (Capital Structure).

Murray Goulburn is Australia’s largest dairy foods company, supplying dairy foods and products domestically and internationally with its flagship Devondale, Liddells and Murray Goulburn Ingredients brands. 

Clifford Chance has advised Luzheng Futures on its US$118 million IPO. This is the first IPO for a mainland Chinese futures company.

Partner Tim Wang co-led the deal with partner Fang Liu who advised on the US law aspects. They were supported by counsel John Baptist Chan and associates Corey Zhang, Lawrence Zhang and Claire Cao.

Luzheng Futures is the largest futures firm in terms of futures brokerage trading volume in Shandong in 2014 with a diversified futures business and a strategic presence in China.

Noerr is advising the globally operating e-commerce platform Global Fashion Group (GFG) in connection with a financing round and the integration of two additional Brazilian fashion portals. A Noerr team headed by Prof. Dr. Christian Pleister acted for GFC.

Implenia AG completed the placement of CHF 175 million 0.5% subordinated convertible bonds due 2022. The convertible bonds were issued at 100% of their principal amount and, unless previously redeemed, converted or repurchased and cancelled, will mature on 30 June 2022 at 100% of their principal amount. Credit Suisse AG and UBS AG acted as Joint Bookrunners and Zürcher Kantonalbank as Co-Lead Manager.

Italian based Cassiopea SpA announced the launch of its initial public offering on the SIX Swiss Exchange with the publication of the offering memorandum and the start of the bookbuilding process. Cassiopea is a clinical-stage specialty pharmaceutical company focused on developing and commercializing innovative and differentiated medical dermatology products. Since July 1, 2015, the shares of Cassiopea are listed and traded on the SIX Swiss Exchange.